BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17305746)

  • 1. Anosmia as an adverse effect of dorzolamid.
    Turgut B; Türkçüoğlu P; Güler M; Akyol N; Celiker U; Demir T
    Acta Ophthalmol Scand; 2007 Mar; 85(2):228-9. PubMed ID: 17305746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of dorzolamide as added therapy in glaucoma patients with maximum tolerated drug therapy. A pilot study].
    Denk PO; Knorr M; Kriegerowski M; Thiel HJ
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):360-4. PubMed ID: 9333661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual side effect of Dorzolamide.
    Zambarakji HJ; Spencer AF; Vernon SA
    Eye (Lond); 1997; 11 ( Pt 3)():418-9. PubMed ID: 9373489
    [No Abstract]   [Full Text] [Related]  

  • 4. [Local carbonic anhydrase inhibitor dorzolamide: development and properties].
    Pfeiffer N
    Ophthalmologe; 1996 Feb; 93(1):103-18. PubMed ID: 8867167
    [No Abstract]   [Full Text] [Related]  

  • 5. [Successful pressure decrease and improved patient quality of life by Trusopt].
    Prell R
    Klin Monbl Augenheilkd; 1996 Apr; 208(4):11-2. PubMed ID: 8778487
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of systemic acetazolamide and topical dorzolamide.
    Epstein R; Brown SV; Dennis RF; Konowal-Allen A
    Ophthalmology; 1998 Sep; 105(9):1581-2. PubMed ID: 9754157
    [No Abstract]   [Full Text] [Related]  

  • 7. Trusopt, a topical carbonic anhydrase inhibitor.
    Donohue EK; Wilensky JT
    J Glaucoma; 1996 Feb; 5(1):68-74. PubMed ID: 8795737
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical dorzolamide and metabolic acidosis in a neonate.
    Morris S; Geh V; Nischal KK; Sahi S; Ahmed MA
    Br J Ophthalmol; 2003 Aug; 87(8):1052-3. PubMed ID: 12881361
    [No Abstract]   [Full Text] [Related]  

  • 9. European Glaucoma Prevention Study.
    Quigley HA
    Ophthalmology; 2005 Sep; 112(9):1642-3; author reply 1643-5. PubMed ID: 16139678
    [No Abstract]   [Full Text] [Related]  

  • 10. Allergic contact dermatitis from timolol and dorzolamide eye drops.
    Kalavala M; Statham BN
    Contact Dermatitis; 2006 Jun; 54(6):345. PubMed ID: 16787459
    [No Abstract]   [Full Text] [Related]  

  • 11. Update in glaucoma: the new pharmacotherapies. Dorzolamide hydrochloride.
    Gould LF
    Can J Ophthalmol; 1998 Aug; 33(5):253-4; discussion 257-8. PubMed ID: 9740951
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical brinzolamide and metabolic acidosis.
    Menon GJ; Vernon SA
    Br J Ophthalmol; 2006 Feb; 90(2):247-8. PubMed ID: 16424547
    [No Abstract]   [Full Text] [Related]  

  • 14. [Harmful effects of common drugs on the visual apparatus. Diuretics].
    Watillon M; Robe-Vanwyck A
    Bull Soc Belge Ophtalmol; 1972; 160(1):215-37. PubMed ID: 5047212
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops.
    Flórez A; Rosón E; Conde A; González B; García-Doval I; de la Torre C; Cruces M
    J Am Acad Dermatol; 2005 Nov; 53(5):909-11. PubMed ID: 16243161
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of Cosopt in glaucoma treatment].
    Călugăru D; Călugăru M
    Oftalmologia; 2008; 52(4):15-25. PubMed ID: 19354158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dorzolamide-induced choroidal detachment in a surgically untreated eye.
    Goldberg S; Gallily R; Bishara S; Blumenthal EZ
    Am J Ophthalmol; 2004 Aug; 138(2):285-6. PubMed ID: 15289139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrolithiasis with dorzolamide.
    Carlsen J; Durcan J; Zabriskie N; Swartz M; Crandall A
    Arch Ophthalmol; 1999 Aug; 117(8):1087-8. PubMed ID: 10448757
    [No Abstract]   [Full Text] [Related]  

  • 19. Irreversible corneal decompensation in patients treated with topical dorzolamide.
    Adamsons I
    Am J Ophthalmol; 1999 Dec; 128(6):774-6. PubMed ID: 10612524
    [No Abstract]   [Full Text] [Related]  

  • 20. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.